Literature DB >> 12571861

Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.

Marion A J van Rossum1, Aeilko H Zwinderman, Maarten Boers, Ben A C Dijkmans, Renée M van Soesbergen, Theo J W Fiselier, Marcel J A M Franssen, Rebecca ten Cate, Lisette W A van Suijlekom-Smit, Nico M Wulffraat, Wietse Kuis, Wilma H J van Luijk, Johanna C M Oostveen, Piet F Dijkstra.   

Abstract

OBJECTIVE: To describe radiologic features of patients with juvenile idiopathic arthritis (JIA) in a standardized manner, to test the reliability and feasibility of this description, and to correlate these features with clinical signs as a first step in the development of a standardized assessment method.
METHODS: The placebo-controlled study of sulfasalazine in patients with oligoarticular, extended oligoarticular, and polyarticular JIA performed by the Dutch Juvenile Idiopathic Arthritis Study Group yielded the data for this study. All trial entry radiographs (clinically involved joints and contralateral joints) were scored (in consensus by a skeletal radiologist and pediatric rheumatologist) for the presence of swelling, osteopenia, joint space narrowing, growth abnormalities, subchondral bone cysts, erosions, and malalignment.
RESULTS: Data on 67 of 69 patients were analyzed. The mean age was 9.1 years (range 2.5-17.6 years), and the median disease duration was 24 months (range 5-176 months). Thirteen percent of the patients were IgM rheumatoid factor (IgM-RF) positive, and 16% were HLA-B27 positive. All 68 clinically evaluated joints were included in the maximum of 19 radiographed joints (or joint groups) per patient. The mean number of radiographed joints per patient was 7 (range 2-15); knees, hands, ankles, and feet were most frequently affected. Fifty-eight patients (87%) had radiologic abnormalities in at least one joint (soft-tissue swelling in 63% of patients, growth disturbances in 48%, joint space narrowing in 28%, and erosions in 15%). In total, half of the radiographs of the clinically involved joints showed radiologic abnormalities, including two-thirds of the radiographs of the clinically affected hands and knees. Univariate analysis revealed a good correlation between the overall articular (clinical) severity and the presence of radiologic abnormalities (odds ratio [OR] 1.38, P < 0.0001). Multivariate analysis showed increased ORs for the presence of radiologic abnormalities and IgM-RF positivity (OR 4.6, P = 0.005) or HLA-B27 positivity (OR 3.0, P = 0.004). In general, reproducibility of the radiologic scoring method was good (mean kappa coefficient of 0.74 [range 0.40-0.86]), although there were scoring discrepancies for swelling, osteopenia, and growth disturbances. The scoring took 10-20 minutes per patient.
CONCLUSION: Our model of describing and scoring radiologic abnormalities of radiographed joints in JIA was feasible, mostly reproducible, correlated well with the overall articular severity score, and added substantial new information not available on clinical examination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571861     DOI: 10.1002/art.10783

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  Familial early onset sarcoidosis with bone cysts and erosions.

Authors:  Norbert Blank; Regina Max; Frank Autschbach; Martin Libicher; Hanns-Martin Lorenz
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

Review 2.  [Imaging options in pediatric rheumatology].

Authors:  D Windschall
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

Review 3.  Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis.

Authors:  Maria Beatrice Damasio; Clara Malattia; Alberto Martini; Paolo Tomà
Journal:  Pediatr Radiol       Date:  2010-04-30

4.  Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study.

Authors:  Dagnachew W Workie; T Brent Graham; Tal Laor; Akila Rajagopal; Kendall J O'Brien; Wendy A Bommer; Judy M Racadio; Norah J Shire; Bernard J Dardzinski
Journal:  Pediatr Radiol       Date:  2007-03-31

Review 5.  Advances and challenges in imaging in juvenile idiopathic arthritis.

Authors:  Silvia Magni-Manzoni; Clara Malattia; Stefano Lanni; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

Review 6.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

7.  Reliability and responsiveness of the Juvenile Arthritis MRI Scoring (JAMRIS) system for the knee.

Authors:  Robert Hemke; Marion A J van Rossum; Mira van Veenendaal; Maaike P Terra; Eline E Deurloo; Milko C de Jonge; J Merlijn van den Berg; Koert M Dolman; Taco W Kuijpers; Mario Maas
Journal:  Eur Radiol       Date:  2012-10-20       Impact factor: 5.315

8.  Increasing feasibility and patient comfort of MRI in children with juvenile idiopathic arthritis.

Authors:  Robert Hemke; Mira van Veenendaal; Taco W Kuijpers; Marion A J van Rossum; Mario Maas
Journal:  Pediatr Radiol       Date:  2012-01-13

9.  Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study.

Authors:  Janneke Anink; Charlotte M Nusman; Lisette W A van Suijlekom-Smit; Rick R van Rijn; Mario Maas; Marion A J van Rossum
Journal:  Arthritis Res Ther       Date:  2014-08-27       Impact factor: 5.156

10.  Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus.

Authors:  Kota Ishida; Katsuhisa Shiraki; Takashi Yoshiyasu
Journal:  Drugs R D       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.